Hjem › Autoimmune sygdomme › Florida
Autoimmune sygdomme kliniske forsøg i Florida
20 studier for Autoimmune sygdomme søger deltagere på steder i Florida.
Byer i Florida
- Miami6 studier
- Jacksonville6 studier
- Orlando4 studier
- Tampa4 studier
- St. Petersburg3 studier
- Gainesville3 studier
Officiel studietekst (engelsk)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Res Of W Florida, Clearwater
- Clinical Research of West Florida Inc, Tampa
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07621809Secukinumab Open Label Roll-over Extension Protocol
- Rheumatology Associates of South Florida, Boca Raton
- FL Medical Clinic Orlando Health, Zephyrhills
RekruttererFase 4
Alder 6 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT04638647A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
RekruttererFase 2
Alder 18 til 60 · Alle køn · Opdateret 25. sep. 2026 · NCT07541287Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Miami Clinical Research, Miami
- GCP Clinical Research, Tampa
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT07513181RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
- Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- University of Miami Hospital, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07182227A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Mayo Clinic, Jacksonville
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 17. aug. 2026 · NCT06858319RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic Florida, Jacksonville
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 13. aug. 2026 · NCT06359041A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Southern Florida, St. Petersburg
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-100, Miami
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 31. jul. 2026 · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1006, Clearwater
- Site Number - 1037, Ormond Beach
- Site Number - 1002, Port Charlotte
- og 2 flere
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Miami, Miami
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 29. jul. 2026 · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Florida Shands Medical Center, Gainesville
- Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
- University of Miami (peds), Miami
- og 6 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT06626919Rheumatology Diet Study
- UCF Health Clinics, Orlando
RekruttererObservationsstudie
Alder 18 til 65 · Alle køn · Opdateret 6. dec. 2024 · NCT06339957Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.